Sign In
Buy JNJ
$244.88
+3.88 (+1.61%)
At Close: Jun 25, 2026
J&J (JNJ) Seeks Expanded Use of Tremfya for Ulcerative Colitis
06:41am, Tuesday, 12'th Mar 2024
Tremfya is an important drug in J&J's (JNJ) immunology drugs portfolio and a key driver of top-line growth.
Johnson & Johnson (JNJ) Increases Despite Market Slip: Here's What You Need to Know
06:51pm, Monday, 11'th Mar 2024
The latest trading day saw Johnson & Johnson (JNJ) settling at $161.23, representing a +1.07% change from its previous close.
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
04:30pm, Monday, 11'th Mar 2024
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, April 16th to review first-quarter results. Joaqui
Looking To Start Earning Passive Income in March? Here Are 6 Top Dividend Stocks
02:45pm, Monday, 11'th Mar 2024
Are you ready for retirement? Planning for retirement can be overwhelming, that's why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
3 Dividend Kings of Healthcare Stocks to Buy Hand Over Fist in March
05:35am, Monday, 11'th Mar 2024
Johnson & Johnson's stellar fundamentals make it a no-brainer. Becton, Dickinson is an underrated compounder with decades of excellence.
5 Dividend Aristocrats Signal Buy In March With 6 To Watch
05:04am, Monday, 11'th Mar 2024
"Dividend Aristocrats in the S&P 500 Index… have raised their annual payouts every year for at least 25 consecutive years." - Kiplinger.com/Investing. 67 Aristocrats, screened as of March 6, 2024, r
The Top 3 Pharma Stocks to Buy in March2024
01:00pm, Saturday, 09'th Mar 2024
Investors' eyes are closely following the massive rally in pharmaceutical stocks amid the red-hot anti-obesity market. In 2024, the projected revenue for the pharma market is estimated to reach $1.15
3 Dividend Aristocrat Stocks to Buy And Hold: March 2024
04:32pm, Friday, 08'th Mar 2024
Dividend Aristocrats are stocks that have grown their dividends for at least 25 consecutive years. Most of these companies have achieved such long dividend growth streaks thanks to their strong busine
The Top 3 Healthcare Stocks to Buy in March 2024
12:27pm, Thursday, 07'th Mar 2024
Stock markets are reaching new highs and exuberance is in the air. For value investors, this might seem like a perplexing time.
The Top 3 Blue-Chip Stocks to Buy in March 2024
11:11am, Thursday, 07'th Mar 2024
When exploring options for top blue-chip stocks to buy, investors are drawn to the perfect blend of stability and growth offered by these reliable equities. Investors often gravitate toward blue-chip
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
10:06am, Wednesday, 06'th Mar 2024
Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
The Top 7 Dividend Stocks to Buy in March 2024
06:17am, Wednesday, 06'th Mar 2024
Investors can effectively unlock financial freedom with dividend stocks to buy for a passive income stream. The key to invest in dividend stocks, promising a consistent and growing payout while offeri
7 No-Frills Dividend Stocks for Your Must-Own List
04:08pm, Tuesday, 05'th Mar 2024
Dividends are a signal to investors of a profitable business. Typically the most successful companies pay investors to own their stock.
Latest J&J talc trial ends with hung jury
03:34pm, Tuesday, 05'th Mar 2024
The latest trial over claims that Johnson & Johnson's talc products cause cancer ended in a mistrial on Tuesday, as a Florida state court jury said it could not agree on a verdict.
Johnson & Johnson (JNJ) Management presents at Cowen 44th Annual Health Care Conference (Transcript)
07:09pm, Monday, 04'th Mar 2024
Johnson & Johnson (NYSE:JNJ ) Cowen 44th Annual Health Care Conference Call March 4, 2024 11:10 AM ET Company Participants Hani Abouhalka - Company Group Chairman, Robotics and Digital, Johnson & John
